HARP

Harpoon Therapeutics Inc: Strategic Merger and Corporate Restructuring

PremiumCompany Announcements

8M ago

Harpoon Therapeutics downgraded to Neutral from Buy at Citi

PremiumThe Fly

9M ago

Harpoon Therapeutics Nears Merger Completion with Merck

PremiumCompany Announcements

9M ago

PremiumCompany AnnouncementsHarpoon Therapeutics Announces Reverse Stock Split Update

10M ago

The Fly

Harpoon Therapeutics downgraded to Market Perform from Outperform at TD Cowen

10M ago

The Fly

Biotech Alert: Searches spiking for these stocks today

10M ago

Biotech Alert: Searches spiking for these stocks today

NBY

PremiumThe Fly

10M ago

Biotech Alert: Searches spiking for these stocks today

NBY

PremiumThe Fly

10M ago

Oppenheimer raises Harpoon target, wonders if Merck deal could be starting point

AMPE

PremiumThe Fly

10M ago

Harpoon Therapeutics downgraded to Hold from Buy at Canaccord

PremiumThe Fly

10M ago

PremiumThe FlyHarpoon Therapeutics downgraded to Neutral from Buy at H.C. Wainwright

10M ago

Market News

M & A News: Merck (NYSE:MRK) to Acquire Harpoon for $680 Million

10M ago

The Fly

Merck to acquire Harpoon Therapeutics for $23.00 per share in cash

10M ago

M & A: Merck (NYSE:MRK) Bolsters Oncology Portfolio With Harpoon Deal

PremiumMarket News

10M ago

Harpoon Therapeutics initiated with an Outperform at Oppenheimer

PremiumThe Fly

10M ago

Harpoon Therapeutics appoints James Bucher as CLO, Wendy Chang as CPO

PremiumThe Fly

11M ago

ELYM

Harpoon Therapeutics price target raised by $4.50 at H.C. Wainwright, here’s why

PremiumThe Fly

11M ago

PremiumThe FlyHarpoon Therapeutics presents HPN217 Phase 1 data in RRMM

11M ago

The Fly

Harpoon Therapeutics files to sell 25.75M shares of common stock for holders

11M ago

The Fly

Harpoon Therapeutics initiated with an Outperform at TD Cowen

12M ago

AMGN